Innovating Works

INS

SOFAR: SOuthern aFrica research cApacity netwoRk The SOuthern aFrica Research cApacity netwoRk (SOFAR) will train a generation of innovative world class and resilient African scientists, cl...
2024-09-13 - 2029-03-31 | Financiado
GenPath Africa: GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA Instituto Nacional de Saúde participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The overall goal of GenPath Africa is to control pathogen infections in Africa. Our consortium of African and European investigators propose...
2023-08-28 - 2027-04-30 | Financiado
DRTB-HDT: STRATIFIED HOST DIRECTED THERAPY FOR DRUG RESISTANT TUBERCULOSIS A RANDOMIZED CONTROLLED MULTI CENT... Instituto Nacional de Saúde participó en un H2020: H2020-SC1-BHC-2018-2020 Tuberculosis is a leading cause of morbidity and mortality worldwide. Current TB treatments are inadequate, requiring patients closely adher...
2019-12-19 - 2025-12-31 | Financiado
EHVA: European HIV Vaccine Alliance EHVA a EU platform for the discovery and evaluation of novel prophy... Instituto Nacional de Saúde participó en un H2020: H2020-PHC-2014-2015 Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. T...
2015-12-17 - 2023-12-31 | Financiado
EMI-TB: Eliciting Mucosal Immunity to Tuberculosis Instituto Nacional de Saúde participó en un H2020: H2020-PHC-2014-2015 Tuberculosis (TB) is a global health problem, killing 1.5 million of people every year. The only currently available vaccine, Mycobacterium...
2014-11-26 - 2019-06-30 | Financiado
CUT'HIVAC: Cutaneous and Mucosal HIV Vaccination Instituto Nacional de Saúde participó en un FP7: Despite significant effort over the past decade to design and implement new vaccines strategies against HIV, no one has met its promise to p...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.